Intrommune Therapeutics
Developing a convenient solution to peanut and other food allergies that is as simple as brushing your teeth - normal is within reach.
- Stage Product In Development
- Industry Biotechnology
- Location New York, NY, USA
- Currency USD
- Founded December 2013
- Employees 4
- Incorporation Type LLC
- Website intrommune.com
Company Summary
Intrommune Therapeutics is a New York based biotechnology company developing a new, simple treatment for peanut and other food allergies. The company’s toothpaste drug delivery platform offers an easy and safe way to retrain the immune system to reduce the risk of symptoms of food allergy, like throat swelling, stomach upset or even a life-threatening drop in blood pressure.
Team
-
Chief Executive Officer
-
Chief Scientific Officer
Advisors
-
Danya GlabauUnconfirmedSteve LaumasUnconfirmed
-
Michael MindlinUnconfirmedDr. Wesley BurksUnconfirmed
-
Dr. David FleischerUnconfirmedDr. Matthew GreenhawtUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.